Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
To be clear, this data targets obese individuals medically defined as having a BMI of 35 to 39.9, with weight-related health issues or a BMI equal to or greater than 40
Studies in which insulin was titrated aggressively to obtain glycemic control resulted in less weight loss
Each vial ships with a documented Certificate of Analysis available on request, including HPLC chromatograms and mass spectrometry confirmation of identity
Regular monitoring and follow-up with your healthcare provider will help tailor the dosage to achieve optimal results
As with other drugs in the incretin-based therapy class, the most commonly reported side effects of retatrutide in clinical trials have been gastrointestinal in nature
Identifying subjects earlier in the disease course might provide the opportunity for testing the efficacy of an earlier UA intervention when the majority of dopaminergic neurons remain intact
